Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/21/2022 | Press release | Distributed by Public on 01/21/2022 07:14
Please select the service you want to use:
Smartlinks | Capstone Green Energy Corporation | News | Environment | Energy Saving | Environmental Policy | Climate Change | Local News | Politics and Policy | Environmental Policy | Policy and Regulation | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Contracts and Orders | Energy | Energy Saving | Renewable Energy Industry | Information Technology | Software | Electrical Components and Equipment Manufacturers | Public Companies | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact